$\require{mediawiki-texvc}$

연합인증

연합인증 가입 기관의 연구자들은 소속기관의 인증정보(ID와 암호)를 이용해 다른 대학, 연구기관, 서비스 공급자의 다양한 온라인 자원과 연구 데이터를 이용할 수 있습니다.

이는 여행자가 자국에서 발행 받은 여권으로 세계 각국을 자유롭게 여행할 수 있는 것과 같습니다.

연합인증으로 이용이 가능한 서비스는 NTIS, DataON, Edison, Kafe, Webinar 등이 있습니다.

한번의 인증절차만으로 연합인증 가입 서비스에 추가 로그인 없이 이용이 가능합니다.

다만, 연합인증을 위해서는 최초 1회만 인증 절차가 필요합니다. (회원이 아닐 경우 회원 가입이 필요합니다.)

연합인증 절차는 다음과 같습니다.

최초이용시에는
ScienceON에 로그인 → 연합인증 서비스 접속 → 로그인 (본인 확인 또는 회원가입) → 서비스 이용

그 이후에는
ScienceON 로그인 → 연합인증 서비스 접속 → 서비스 이용

연합인증을 활용하시면 KISTI가 제공하는 다양한 서비스를 편리하게 이용하실 수 있습니다.

Polymer-bound paclitaxel derivatives 원문보기

IPC분류정보
국가/구분 United States(US) Patent 등록
국제특허분류(IPC7판)
  • A61K-031/765
  • C80F-222/38
출원번호 US-0077065 (1993-06-16)
우선권정보 GB-0013077 (1992-06-19)
발명자 / 주소
  • Mongelli Nicola (Milan ITX) Angelucci Francesco (Milan ITX) Pesenti Enrico (Cologno Monzese ITX) Suarato Antonino (Milan ITX) Biasoli Giovanni (Gavirate ITX)
출원인 / 주소
  • Farmitalia Carlo Erba S.r.l. (Milan ITX 03)
인용정보 피인용 횟수 : 109  인용 특허 : 0

초록

A polymer conjugate consisting essentially of: from 90 to 99.9 mol % of units represented by the formula [Figure] from 0.1 to 5 mol % of units represented by the formula [Figure] wherein one of R1 and R2 is a copolymer residue of the formula [Figure] and the other one is hydrogen atom; from 0 to 9.9

대표청구항

A polymer conjugate consisting essentially of: from 90 to 99.9 mol % of units represented by the formula [Figure] from 0.1 to 5 mol % of units represented by the formula [Figure] wherein one of R1 and R2 is a copolymer residue of the formula [Figure] and the other one is hydrogen atom; from 0 to 9.9

이 특허를 인용한 특허 (109)

  1. Mickle, Travis; Krishnan, Suma; Bishop, Barney; Lauderback, Christopher; Moncrief, James Scott; Oberlender, Rob; Piccariello, Thomas; Paul, Bernhard J.; Verbicky, Christopher A., Abuse resistant lysine amphetamine compounds.
  2. Mickle,Travis; Krishnan,Suma; Moncrief,James Scott; Lauderback,Christopher; Bishop,Barney; Oberlender,Rob; Piccariello,Thomas, Abuse resistant lysine amphetamine compounds.
  3. Mickle,Travis; Krishnan,Suma; Bishop,Barney; Lauderback,Christopher; Moncrief,James Scott; Oberlender,Rob; Piccariello,Thomas, Abuse-resistant amphetamine compounds.
  4. Mickle, Travis; Krishnan, Suma; Bishop, Barney; Lauderback, Christopher; Moncrief, James Scott; Oberlender, Robert; Piccariello, Thomas; Paul, Bernhard J.; Verbicky, Christopher A., Abuse-resistant amphetamine prodrugs.
  5. Mickle, Travis; Krishnan, Suma; Bishop, Barney; Lauderback, Christopher; Moncrief, James Scott; Oberlender, Robert; Piccariello, Thomas; Paul, Bernhard J.; Verbicky, Christopher A., Abuse-resistant amphetamine prodrugs.
  6. Mickle, Travis; Krishnan, Suma; Bishop, Barney; Lauderback, Christopher; Moncrief, James Scott; Oberlender, Robert; Piccariello, Thomas; Paul, Bernhard J.; Verbicky, Christopher A., Abuse-resistant amphetamine prodrugs.
  7. Mickle, Travis; Krishnan, Suma; Bishop, Barney; Lauderback, Christopher; Moncrief, James Scott; Oberlender, Robert; Piccariello, Thomas; Paul, Bernhard J.; Verbicky, Christopher A., Abuse-resistant amphetamine prodrugs.
  8. Mickle, Travis; Krishnan, Suma; Bishop, Barney; Lauderback, Christopher; Moncrief, James Scott; Oberlender, Robert; Piccariello, Thomas; Paul, Bernhard J.; Verbicky, Christopher A., Abuse-resistant amphetamine prodrugs.
  9. Mickle, Travis; Krishnan, Suma; Bishop, Barney; Lauderback, Christopher; Moncrief, James Scott; Oberlender, Robert; Piccariello, Thomas; Paul, Bernhard J.; Verbicky, Christopher A., Abuse-resistant amphetamine prodrugs.
  10. Mickle, Travis; Krishnan, Suma; Bishop, Barney; Lauderback, Christopher; Moncrief, James Scott; Oberlender, Robert; Piccariello, Thomas; Paul, Bernhard J.; Verbicky, Christopher A., Abuse-resistant amphetamine prodrugs.
  11. Mickle, Travis; Krishnan, Suma; Bishop, Barney; Lauderback, Christopher; Moncrief, James Scott; Oberlender, Robert; Piccariello, Thomas; Paul, Bernhard J.; Verbicky, Christopher A., Abuse-resistant amphetamine prodrugs.
  12. Mickle, Travis; Krishnan, Suma; Bishop, Barney; Lauderback, Christopher; Moncrief, James Scott; Oberlender, Robert; Piccariello, Thomas; Paul, Bernhard J.; Verbicky, Christopher A., Abuse-resistant amphetamine prodrugs.
  13. Mickle, Travis; Krishnan, Suma; Bishop, Barney; Lauderback, Christopher; Moncrief, James Scott; Oberlender, Robert; Piccariello, Thomas; Paul, Bernhard J.; Verbicky, Christopher A., Abuse-resistant amphetamine prodrugs.
  14. Mickle, Travis; Krishnan, Suma; Bishop, Barney; Lauderback, Christopher; Moncrief, James Scott; Oberlender, Robert; Piccariello, Thomas; Paul, Bernhard J.; Verbicky, Christopher A., Abuse-resistant amphetamine prodrugs.
  15. Mickle, Travis; Krishnan, Suma; Bishop, Barney; Lauderback, Christopher; Moncrief, James Scott; Oberlender, Robert; Piccariello, Thomas; Paul, Bernhard J.; Verbicky, Christopher A., Abuse-resistant amphetamine prodrugs.
  16. Mickle, Travis; Krishnan, Suma; Bishop, Barney; Lauderback, Christopher; Moncrief, James Scott; Oberlender, Robert; Piccariello, Thomas; Paul, Bernhard J.; Verbicky, Christopher A., Abuse-resistant amphetamine prodrugs.
  17. Mickle, Travis; Krishnan, Suma; Bishop, Barney; Lauderback, Christopher; Moncrief, James Scott; Oberlender, Robert; Piccariello, Thomas; Paul, Bernhard J.; Verbicky, Christopher A., Abuse-resistant amphetamine prodrugs.
  18. Mickle, Travis; Krishnan, Suma; Bishop, Barney; Lauderback, Christopher; Moncrief, James Scott; Oberlender, Robert; Piccariello, Thomas; Paul, Bernhard J.; Verbicky, Christopher A., Abuse-resistant amphetamine prodrugs.
  19. Mickle,Travis; Krishnan,Suma; Moncrief,James Scott; Lauderback,Christopher; Miller,Christal, Abuse-resistant hydrocodone compounds.
  20. Mickle,Travis; Krishnan,Suma; Moncrief,James Scott; Mickle,Christal; Lauderback,Christopher; Piccariello,Thomas, Abuse-resistant hydrocodone compounds.
  21. Mickle, Travis; Krishnan, Suma; Moncrief, James Scott; Lauderback, Christopher; Piccariello, Thomas; Kirk, Randal, Active agent delivery systems and methods for protecting and administering active agents.
  22. Mickle,Travis; Krishnan,Suma; Moncrief,James Scott; Lauderback,Christopher; Piccariello,Thomas; Kirk,Randal, Active agent delivery systems and methods for protecting and administering active agents.
  23. Piccariello, Thomas; Olon, Lawrence P.; Kirk, Randall J., Active agent delivery systems and methods for protecting and administering active agents.
  24. Piccariello,Thomas; Kirk,Randal J.; Mickle,Travis, Active agent delivery systems and methods for protecting and administering active agents.
  25. Hunter, William L.; Machan, Lindsay S.; Arsenault, A. Larry, Anti-angiogenic compositions and methods of use.
  26. Hunter, William L.; Machan, Lindsay S.; Arsenault, A. Larry, Anti-angiogenic compositions and methods of use.
  27. Hunter, William L.; Machan, Lindsay S.; Arsenault, A. Larry, Anti-angiogenic compositions and methods of use.
  28. Hunter, William L.; Machan, Lindsay S.; Arsenault, A. Larry, Anti-angiogenic compositions and methods of use.
  29. Béliveau, Richard; Demeule, Michel; Che, Christian; Regina, Anthony, Aprotinin-like polypeptides for delivering agents conjugated thereto to tissues.
  30. Hoffmann, Erika; Horres, Roland; Faust, Volker; Schreiber, Helmut; Von Holst, Armin; Hoffmann, Michael, Balloon catheter for treating stenosis of body passages and for preventing threatening restenosis.
  31. Francesco Angelucci IT; Gabriele Fachin IT; Valeria Caiolfa IT; Antonino Suarato IT, Bioactive derivatives of camptothecin.
  32. Lynn, David M.; Miller, Adam D., Charge-dynamic polymers and delivery of anionic compounds.
  33. Owens, Michael Sean; Swee, Michael; Larson, Dennis; Blaskowsi, Stacie, Coating process for drug delivery balloons using heat-induced rewrap memory.
  34. Rothbard, Jonathan B.; Wender, Paul A.; McGrane, P. Leo; Sista, Lalitha V. S.; Kirschberg, Thorsten A., Compositions and methods for enhancing drug delivery across and into epithelial tissues.
  35. Rothbard, Jonathan B.; Wender, Paul A.; McGrane, P. Leo; Sista, Lalitha V. S.; Kirschberg, Thorsten A., Compositions and methods for enhancing drug delivery across and into epithelial tissues.
  36. Rothbard, Jonathan B.; Wender, Paul A.; McGrane, P. Leo; Sista, Lalitha V. S.; Kirschberg, Thorsten A., Compositions and methods for enhancing drug delivery across and into epithelial tissues.
  37. Rothbard, Jonathan B.; Wender, Paul A.; McGrane, P. Leo; Sista, Lalitha V. S.; Kirschberg, Thorsten A., Compositions and methods for enhancing drug delivery across and into epithelial tissues.
  38. Rothbard, Jonathan B.; Wender, Paul A.; McGrane, Leo P.; Sista, Lalitha V. S.; Kirschberg, Thorsten A., Compositions and methods for enhancing drug delivery across and into ocular tissues.
  39. Rothbard, Jonathan B.; Wender, Paul A.; McGrane, P. Leo; Sista, Lalitha V. S.; Kirschberg, Thorsten A., Compositions and methods for enhancing drug delivery across and into ocular tissues.
  40. Rothbard,Jonathan B.; Wender,Paul A.; McGrane,P. Leo; Sista,Lalitha V. S.; Kirschberg,Thorsten A., Compositions and methods for enhancing drug delivery across and into ocular tissues.
  41. Rothbard, Jonathan B.; Wender, Paul A.; McGrane, P. Leo; Sista, Lalitha V. S.; Kirschberg, Thorsten A., Compositions and methods for treating inflammatory diseases of the skin.
  42. Hunter, William L.; Machan, Lindsay S., Compositions and methods for treating or preventing diseases of body passageways.
  43. Mickle,Travis; Krishnan,Suma; Moncrief,James Scott; Lauderback,Christopher; Bera,Sanjib; Guenther,Sven; Hirschelman,Wendy, Compounds and compositions for prevention of overdose of oxycodone.
  44. Moncrief, James Scott; Krishnan, Suma; Mickle, Travis; Lauderback, Christopher; Bera, Sanjib; Guenther, Sven; Hirschelman, Wendy, Compounds and compositions for prevention of overdose of oxycodone.
  45. Castaigne, Jean-Paul; Demeule, Michel; Gagnon, Catherine; Lawrence, Betty, Conjugates of GLP-1 agonists and uses thereof.
  46. Castaigne, Jean-Paul; Demeule, Michel; Che, Christian; Thiot, Carine; Gagnon, Catherine, Conjugates of neurotensin or neurotensin analogs and uses thereof.
  47. Brem Henny ; Langer Robert S. ; Domb Abraham J.,ILX, Controlled local delivery of chemotherapeutic agents for treating solid tumors.
  48. Brem Henry (Lutherville MD) Langer Robert S. (Newton MA) Domb Abraham J. (Efrat ILX), Controlled local delivery of chemotherapeutic agents for treating solid tumors.
  49. Shashoua Victor E. ; Swindell Charles S. ; Webb Nigel L. ; Bradley Matthews O., DHA-pharmaceutical agent conjugates of taxanes.
  50. Shashoua,Victor E.; Swindell,Charles E.; Webb,Nigel L.; Bradley,Matthews O., DHA-pharmaceutical agent conjugates of taxanes.
  51. Zhao, Jonathon Z., Device for local and/or regional delivery employing liquid formulations of therapeutic agents.
  52. Zhao, Jonathon Z., Device for local and/or regional delivery employing liquid formulations of therapeutic agents.
  53. Shashoua, Victor E.; Swindell, Charles E.; Webb, Nigel L.; Bradley, Matthews O., Dha-pharmaceutical agent conjugates to improve tissue selectivity.
  54. Zhao, Jonathon Z., Drug coated expandable devices.
  55. Shuichi Sugawara JP; Masahiro Kajiki JP; Hiroshi Kuriyama JP; Nobuya Kitaguchi JP, Drug complex.
  56. Demeule, Michel; Che, Christian; Gabathuler, Reinhard; Yang, Gaoqiang, Etoposide and doxorubicin conjugates for drug delivery.
  57. Dave, Vipul; Falotico, Robert; Zhao, Jonathon Z., Extraction of solvents from drug containing polymer reservoirs.
  58. Webb,Nigel L.; Bradley,Matthews O.; Anthony,Forrest; Fisher,Mark, Fatty acid-anticancer conjugates and uses thereof.
  59. Webb, Nigel L.; Bradley, Matthews O.; Swindell, Charles S.; Shashoua, Victor E., Fatty acid-pharmaceutical agent conjugates.
  60. Swindell, Charles S.; Fegley, Glenn J., Fatty alcohol drug conjugates.
  61. Swindell, Charles S.; Fegley, Glenn J., Fatty amine drug conjugates.
  62. Desai, Neil P.; Soon-Shiong, Patrick, Formulations of pharmacological agents, methods for the preparation thereof and methods for the use thereof.
  63. Sarasam, Aparna Reddy; Barnett, Angela Rose; Gearhart, Krista Nicole; Lichti, Jason; Reyes, Priscilla, Implantable medical device coatings with biodegradable elastomer and releasable taxane agent.
  64. Falotico, Robert; Zhao, Jonathon Z., Injectable formulations of taxanes for cad treatment.
  65. Falotico, Robert; Zhao, Jonathon Z., Injectable formulations of taxanes for cad treatment.
  66. Piccariello,Thomas; Olon,Lawrence Peter; Goldstein,Alex Saunders; Moncrief,James Scott; Boerth,Nancy Johnston, Iodothyronine compositions.
  67. Michal, Eugene T.; Lerner, Daniel J.; Pollman, Matthew J., Local delivery of water-soluble or water-insoluble therapeutic agents to the surface of body lumens.
  68. Kangas, Steve; Feng, James; Chen, Yen-Lane; Zeng, Maggie, Medical device with crystalline drug coating.
  69. Hoffmann, Erika; Horres, Roland; Faust, Volker; Schreiber, Helmut; Von Holst, Armin; Hoffmann, Michael, Medical product for treating stenosis of body passages and for preventing threatening restenosis.
  70. Beliveau, Richard; Gingras, Denis; Nyalendo, Carine, Membrane type-1 matrix metalloprotein inhibitors and uses thereof.
  71. Béliveau, Richard; Demeule, Michel, Method for transporting a compound across the blood-brain barrier.
  72. Ruane, Patrick H.; Perez-Segarra, Waleska; Ragheb, Anthony O.; Fearnot, Neal E.; Voorhees, III, William D.; Bates, Brian L.; Osborne, Thomas A., Method of delivering an implantable medical device with a bioabsorbable coating.
  73. Webb, Nigel L.; Bradley, Matthews O.; Swindell, Charles S.; Shashoua, Victor E., Method of treating a liver disorder with fatty acid-antiviral agent conjugates.
  74. Ruoslahti, Erkki; Simberg, Dmitri, Methods and compositions related to clot binding compounds.
  75. Zeng, Maggie; Chen, Yen-Lane; Romanshek, Maura; Meyer, Erin, Methods of converting amorphous drug substance into crystalline form.
  76. Jackson, John K.; Zastre, Jason; Burt, Helen M., Micellar drug delivery systems for hydrophobic drugs.
  77. Castaigne, Jean-Paul; Demeule, Michel; Che, Christian; Thiot, Carine; Gagnon, Catherine; Lawrence, Betty, Multimeric peptide conjugates and uses thereof.
  78. Kangas, Steve; Owens, Michael Sean; Patterson, Jon; Ekberg, Dave; Haun, Erik; Henderson, Eric; Foss, Aaron; Chen, Yen-Lane, Nucleation of drug delivery balloons to provide improved crystal size and density.
  79. Koivunen,Erkki; Gahmberg,Carl G., Peptide ligands of leukocyte integrins.
  80. Kirk,Randal J.; Latham,Keith R., Pharmaceutical composition containing an active agent in an amino acid copolymer structure.
  81. Mickle, Travis; Krishnan, Suma; Moncrief, James Scott; Lauderback, Christopher, Pharmaceutical compositions for prevention of overdose or abuse.
  82. Mickle,Travis; Krishnan,Suma; Moncrief,James Scott; Lauderback,Christopher; Mickle,Christal, Pharmaceutical compositions for prevention of overdose or abuse.
  83. Demeule, Michel; Che, Christian; Regina, Anthony; Béliveau, Richard; Gagnon, Catherine; Castaigne, Jean-Paul; Gabathuler, Reinhard, Pharmaceutical compositions of paclitaxel, paclitaxel analogs or paclitaxel conjugates and related methods of preparation and use.
  84. Bhatt,Rama; Vries,Peter de; Klein,J. Peter; Tulinsky,John; Lewis,Robert A.; Singer,Jack W., Polyglutamic acid-camptothecin conjugates and methods of preparation.
  85. Bhatt,Rama; Vries,Peter de; Klein,J. Peter; Tulinsky,John; Lewis,Robert A.; Singer,Jack W., Polyglutamic acid-camptothecin conjugates and methods of preparation.
  86. Angelucci Francesco,ITX ; Suarato Antonino,ITX, Polymer-bound camptothecin derivatives.
  87. Mongelli Nicola,ITX ; Angelucci Francesco,ITX ; Pesenti Enrico,ITX ; Suarato Antonino,ITX ; Biasoli Giovanni,ITX, Polymer-bound paclitaxel derivatives.
  88. Duncan Ruth,GBX ; Evagorou Evagoras G.,GBX ; Buckley Robert G.,GBX ; Gianasi Elisabetta,GBX, Polymer-platinum compounds.
  89. Duncan Ruth,GBX ; Ferruti Paolo,ITX ; Evagorou Evagoras G.,GBX, Polymer-platinum compounds.
  90. Angelucci Francesco,ITX ; Orzi Fabrizio,ITX ; Fachin Gabriele,ITX ; Caiolfa Valeria,ITX ; Zamai Moreno,ITX ; Suarato Antonino,ITX, Polymeric derivatives of camptothecins.
  91. Ruane, Patrick H., Post-processing of a medical device to control morphology and mechanical properties.
  92. Beliveau, Richard; Demeule, Michel; Che, Christian; Regina, Anthony, Potentiation of anticancer agents.
  93. Béliveau, Richard; Demeule, Michel; Che, Christian; Regina, Anthony, Potentiation of anticancer agents.
  94. Komazawa Hiroyuki,JPX ; Kojima Masayoshi,JPX ; Orikasa Atsushi,JPX, Propenamide derivatives containing Arg-Gly-Asp polymers obtained therefrom.
  95. Dadino, Ronald C.; Zhao, Jonathon Z., Rapamycin coated expandable devices.
  96. Dadino, Ronald C.; Zhao, Jonathon Z., Rapamycin coated expandable devices.
  97. Falotico, Robert; Zhao, Jonathon Z., Solution formulations of sirolimus and its analogs for CAD treatment.
  98. Mickle, Travis; Krishnan, Suma; Moncrief, James Scott; Lauderback, Christopher; Piccariello, Thomas, Sustained release pharmaceutical compounds to prevent abuse of controlled substances.
  99. Bradley Matthews O. ; Shashoua Victor E. ; Swindell Charles S. ; Webb Nigel L., Taxane compounds and compositions.
  100. Swindell Charles S. ; Shashoua Victor E. ; Bradley Matthews O. ; Webb Nigel L., Taxanes.
  101. Bressi Jerome C. ; Douglass ; III James G. ; Seligson Allen ; Sovak Milos, Taxoids.
  102. Castaigne, Jean-Paul; Demeule, Michel; Lawrence, Betty, Treatment of ovarian cancer using an anticancer agent conjugated to an angiopep-2 analog.
  103. Lynn, David M.; Zhang, Jingtao; Liu, Xianghui, Ultrathin multilayered films for controlled release of anionic reagents.
  104. Chun Li ; Sidney Wallace ; Dong-Fang Yu ; David J. Yang, Water soluble paclitaxel derivatives.
  105. Li, Chun; Wallace, Sidney; Yu, Dong-Fang; Yang, David J., Water soluble paclitaxel derivatives.
  106. Li,Chun; Wallace,Sidney; Yu,Dong Fang; Yang,David, Water soluble paclitaxel derivatives.
  107. Li,Chun; Wallace,Sidney; Yu,Dong Fang; Yang,David J., Water soluble paclitaxel derivatives.
  108. Li Chun ; Wallace Sidney ; Yu Dong-Fang ; Yang David J., Water soluble paclitaxel prodrugs.
  109. Li,Chun; Wallace,Sidney; Yu,Dong Fang; Yang,David J., Water soluble paclitaxel prodrugs.
섹션별 컨텐츠 바로가기

AI-Helper ※ AI-Helper는 오픈소스 모델을 사용합니다.

AI-Helper 아이콘
AI-Helper
안녕하세요, AI-Helper입니다. 좌측 "선택된 텍스트"에서 텍스트를 선택하여 요약, 번역, 용어설명을 실행하세요.
※ AI-Helper는 부적절한 답변을 할 수 있습니다.

선택된 텍스트

맨위로